Before the Books Are a Mess: Why the Best Time to Bring In Your CPA Is Day One

 How engaging a strategic accounting partner from the start changes everything for cannabis companies, especially startups.

 There is a common story in cannabis. A founder gets their license, secures a lease, builds out the facility, starts selling, and then—six months or a year in—calls a CPA to "clean up the books." By then, the damage is done: tax positions are indefensible, compliance records are tangled, and the financial picture is so blurry that raising capital or even projecting the next quarter becomes a guessing game.

But what if the CPA showed up before any of that happened? Not as an afterthought, but as a founding partner in the business’s financial architecture?

This is not a hypothetical. It is the direction the entire accounting profession is heading in—and in cannabis, it is a smart practice.

The Industry Is Moving Toward Continuous Partnership

Across the accounting industry, a model called Client Accounting Services—CAS—is reshaping how firms work with businesses. Instead of showing up once a year for tax season, CAS means the accounting team is embedded in the business on an ongoing basis to manage the books, build financial systems, provide real-time visibility, and help leadership make better decisions with better data.

CAS is a move away from time-and-materials billing and toward standardized, tech-enabled, value-priced services. In other words, the CPA stops being someone you call when something breaks down and becomes the person who makes sure it never does.

In Cannabis, Structure Is Strategy

Every industry benefits from early financial planning. But cannabis has a feature that makes it categorically different: IRC Section 280E.

Under 280E, businesses involved in trafficking Schedule I or II controlled substances cannot deduct ordinary business expenses. Because marijuana has remained classified as Schedule I under federal law, state-legal cannabis operators are effectively barred from deducting costs like rent, payroll, and marketing—expenses that every other business take for granted. The only deductions available are those tied to cost of goods sold (COGS).

The practical result is devastating. Cannabis companies routinely face effective tax rates of 60% to 70% or more. One publicly traded multistate operator reported setting aside a reserve of approximately $38 million for a single tax year to cover potential 280E-related liabilities, including interest and penalties. Industry-wide, state-legal cannabis companies paid an estimated $1.8 billion in excess taxes in 2022 alone.

Under 280E, the way you set up your chart of accounts, categorize expenses, and structure your cost allocation is not just an accounting exercise—it determines your tax burden. An expense categorized as COGS is deductible. The same expense classified as Sales, General & Administrative may not be. This is why the IRS has closely scrutinized how cannabis businesses capitalize costs under Section 263A, and why accounting architecture matters from day one.

A CPA who arrives after launch is inheriting decisions that have already been made—often badly. A CPA who is there from the start designs the system so that every dollar is categorized defensibly from the beginning.

The Rescheduling Moment: Opportunity and Complexity

In December 2025, President Trump signed an executive order directing the Attorney General to expedite the rescheduling of marijuana from Schedule I to Schedule III under the Controlled Substances Act. If finalized, this would be the most significant federal cannabis policy shift in over fifty years—and the most immediate consequence would be the elimination of Section 280E for cannabis businesses.

But here is what many operators miss: rescheduling does not simplify your accounting, but probably makes it more complex.

Under 280E, many cannabis businesses took a counterintuitive shortcut. Because most deductions were disallowed anyway, there was less reason to track them meticulously. Once 280E no longer applies, every deduction and credit that was previously irrelevant suddenly becomes available: R&D credits, interest expense deductions under Section 163(j), state-level credits, and more. Companies that never had reason to build robust expense tracking systems will need them then.

Additionally, the transition period itself creates questions that remain unresolved: Will 280E relief apply retroactively to the beginning of the rescheduling year? How should businesses handle protective refund claims for prior years? What entity structure changes (for example, converting from an S corporation to a C corporation) might now be advantageous?

This is precisely the kind of moment where having a CPA already embedded in your operations pays dividends. Someone who knows your books, your structure, and your history will become the difference between capturing the opportunity and scrambling to catch up.

Four Blind Spots a Day-One CPA Catches

Cannabis founders are, by necessity, operators first. They are focused on cultivation, retail, product development, and compliance. The financial architecture of the business is often an afterthought, not because they don’t care, but because they don’t know what they cannot see.

1. Entity Structure Decisions That Cannot Be Easily Undone

The choice between an LLC, S-corp, or C-corp has tax consequences that compound over time. Under 280E, certain structures (like S-corps) created specific disadvantages because high tax liabilities flowed through to the owners’ personal returns. With rescheduling on the horizon, the calculus is changing again—some tax experts suggest that conversion to C-corp status may become advantageous for cannabis partnerships and S-corps once 280E sunsets. A CPA who is there at formation helps the founder make this decision with the full picture, not just the cheapest option from an online incorporation service.

2. Cash Flow Forecasting in a Cash-Heavy Business

Cannabis remains largely a cash business. Most major financial institutions still will not serve cannabis operators, and those that do often charge premium fees. Without proper cash flow modeling, founders frequently underestimate how quickly startup costs consume their capital. Research consistently shows that the majority of startup failures are linked to cash flow mismanagement—and in cannabis, where banking access is limited and regulatory costs are high, the margin for error is even thinner. A CPA can help chart these difficult cash flow waters from the get-go.

3. Cost Allocation and COGS Architecture

Under 280E, the difference between an expense classified as cost of goods sold and one classified as a general operating expense is the difference between deductible and non-deductible. The IRS’s position, as reflected in guidance like Chief Counsel Advice 201504011, is that Section 263A does not convert otherwise non-deductible 280E costs into deductible ones simply by capitalizing them into inventory. Getting this wrong from the start means years of indefensible tax positions and potential audit exposure.

4. Investor-Ready Books

Cannabis companies that want to raise capital—whether from private investors, venture funds, or eventually public markets—need clean, auditable financial statements. Investors want to see GAAP-compliant reporting, clear revenue recognition, and transparent cost structures. Books that were assembled retroactively from shoebox receipts and spreadsheets do not inspire confidence. A CPA embedded from day one produces financials that are always investor-ready, because they were built that way.

Why the Window for “Growing Through Mess” Is Closing

For several years, the cannabis industry’s rapid expansion masked a lot of operational weakness. Revenue was growing fast enough that messy books, rough-guess budgets, and deferred compliance did not feel like emergencies. That era is long over.

The 2025 LeafLink Wholesale Cannabis Pricing Guide reports continued year-over-year pricing declines across product categories. In California—the largest and most mature legal market—taxable cannabis sales in the first quarter of 2025 came in at roughly $1.088 billion, down approximately 11% year over year, reflecting severe legal-market strain.

When prices compress and revenue softens, the companies that survive are the ones with financial visibility: margin clarity at the SKU level, real cash flow discipline, channel profitability data, and books that banks and investors can actually trust. These are not things you build in a crisis.

They are things a CAS-model CPA builds from the beginning.

The Verdant Approach: Your Finance Partner

At VERDANT Strategies, we believe the CPA relationship should start before the first transaction—not after the first problem. Our Client Accounting Services model is built on exactly the philosophy the accounting profession is moving toward: continuous, embedded, strategic partnership.

That means we help cannabis operators design their chart of accounts before they open their doors. We build the systems that reconcile point-of-sale, inventory tracking, and general ledger data from the start. We structure entities and cost allocations to be defensible under 280E—and ready to pivot when the regulatory landscape changes. We model cash flow so founders can see around corners. And we keep the books investor-ready at all times, because you never know when the right opportunity will knock.

The cannabis industry is entering a new chapter.

Rescheduling, price compression, market maturation, and regulatory evolution are converging to create both enormous opportunity and substantial risk. The businesses that thrive will be the ones whose financial foundations were built to last–from the beginning.